Loading...
•
Jun 30, 2021
Balchem Q2 2021 Earnings Report
Reported record second quarter with strong sales growth in all segments.
Key Takeaways
Balchem Corporation reported record second quarter net sales of $202.4 million, a 16.7% increase compared to the prior year quarter. GAAP EPS was $0.70 and adjusted EPS was $0.93. The company experienced a flash flood event at its Verona, Missouri plant, which had a negative direct financial impact of approximately $3.8 million.
Net sales were $202.4 million, an increase of 16.7% compared to the prior year quarter.
Adjusted EBITDA was $50.1 million, an increase of 14.3% from the prior year.
GAAP net earnings were $22.7 million, an increase of 7.6% from the prior year, resulting in GAAP earnings per share of $0.70.
Adjusted net earnings were $30.4 million, an increase of 10.3% from the prior year, resulting in adjusted earnings per share of $0.93.
Balchem
Balchem
Balchem Revenue by Segment
Revenue by Segment
Human Nutrition & Health Revenue
CapyFin.comAnimal Nutrition & Health Revenue
CapyFin.comSpecialty Products Revenue
CapyFin.com Forward Guidance
The second quarter of 2021 was another solid quarter for Balchem. While we faced macro-economic challenges, particularly from significantly higher raw material costs as well as complexities associated with logistical disruptions, we stepped up to meet these challenges and once again delivered a strong financial performance, while at the same time continuing to progress our strategic growth initiatives.
Revenue & Expenses
Visualization of income flow from segment revenue to net income